Objective: to associate the presence and grading of adverse dermatoneurological events (peripheral neuropathy and hand-foot syndrome) and the interference in the activities of daily living of patients with gastrointestinal neoplasms undergoing systemic antineoplastic treatment.
Method: this is a longitudinal, prospective study, using instruments to assess hand-foot syndrome and peripheral neuropathy.
Results: there were 36 patients: 66.